SkyCell
PrivateLast Round
Series D
Jun 25, 2024
Est. Valuation
$600M
Total Funding Raised
$270M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
SkyCell operates in Healthcare & Life Sciences and is based in Zug. Its latest recorded funding round was a Series D round in June 2024.
SkyCell is a logistics and technology company that provides data-driven, temperature-controlled container systems designed to optimize the supply chain for pharmaceutical companies.
Sector
Healthcare & Life Sciences
Verticals
Pharma Supply Chain, Supply Chain Tracking, Circular Economy, IoT Hardware, Logistics Software
Business Model
B2B
Customer Profile
Hardware + Subscription, Usage-Based SaaS, Services & Consulting, Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SkyCell Comparables
Compare SkyCell with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EMBALL'ISO | 76% | |
| Cryoport | 76% | |
| Controlant | 75% |
For institutional investors. Book with your work email.
SkyCell Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Jun 25, 2024 | ||||
| Series D | Oct 31, 2023 | ||||
| Series C | Oct 11, 2021 | ||||
| Growth Equity | Apr 28, 2020 | ||||
| VC Round | Oct 8, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
SkyCell Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Capital Transmission | Growth Equity, VC Round |
| Die Mobiliar | Series C |
| Tybourne Capital Management | Series D |
| M&G Investments | Series D |
| DisruptAD | Series C |
| Swiss Entrepreneurs Fund | Growth Equity, VC Round |
| SHUAA Capital | Series C |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 5, 2026
Received a Platinum Ecovadis rating for sustainability and employee well-being.
- Aug 5, 2026
Cited 'Great Place to Work' award for culture.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- expands_facilitiesSep 14, 2026
SkyCell AG and DHL jointly inaugurate a pharmaceutical logistics service center near Guarulhos Airport in Brazil that supports SkyCell smart containers and can simultaneously prepare, pre-cool, and certify them.
For institutional investors. Book with your work email.
SkyCell Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about SkyCell's valuation, stock price, and market status.
Is SkyCell a public or private company?
SkyCell is a private company.
What is the current stock price of SkyCell?
SkyCell is a private company, so its shares have no public market price. Caplight tracks SkyCell's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SkyCell worth (valuation)?
SkyCell's valuation is estimated at $600.0M based on funding round data.
Can I buy SkyCell stock?
SkyCell shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SkyCell's last funding round?
SkyCell's most recent funding round was Series D on June 25, 2024.
Who are the main investors in SkyCell?
Key investors in SkyCell include M&G Investments, MVM Life Science Partners LLP.
Will SkyCell IPO soon?
No public IPO plans have been announced for SkyCell.
How can I track SkyCell secondary market activity?
Caplight tracks bids, offers, and trades in SkyCell's shares on secondary markets.